Novel dosage forms, improved therapies, continuous processing
METHOCEL™, ETHOCEL™ and POLYOX™ excipients can all be used in hot melt extrusion, with POLYOX™ offering an advantaged processing window.
- Reduced processing time and costs
- Better content uniformity
- Improved bioavailability of poorly soluble drugs
- Combination drugs
- Flexible, small capital footprint manufacturing process that requires no solvents
- Oral dose options – fast/slow dissolve films, tablets and beads
